Bart Barlogie

Bart Barlogie, MD

  • PROFESSOR | Medicine, Hematology and Medical Oncology

Specialty:

Hematology-Oncology

Dr. Bart Barlogie recently joined the Icahn School of Medicine at Mt. Sinai in New York as Director of Myeloma Research. He had previously headed the Myeloma Institute at the University of Arkansas for Medical Sciences, which he founded 26 years ago. Under his leadership, multiple myeloma has become a curable disease when applying his Total Therapy approach – meaning using all active agents upfront, followed by tandem melphalan-based autotransplants, consolidation chemotherapy and maintenance. He is now focusing his attention on the 15% of patients presenting with genomically defined high-risk MM, by applying metronomically scheduled chemotherapy and targeting mutations.

Clinical Focus


Education

MD, Ruprecht-Karl-Universitat

Fellowship, Internal Medicine, MD Anderson Cancer Center (Univ of Texas)

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.